出血性疾患検査の世界市場規模調査・予測：製品タイプ別、適応症別、エンドユーザー別、地域別分析、2022-2029年

世界の出血性疾患検査市場は、2021年に約8260万米ドルと評価され、予測期間2022-2029年には7.8％以上の健全な成長率で成長すると予想されています。

出血性疾患は、血液凝固プロセスに影響を与え、過剰な出血をもたらす状態です。この疾患は、血液中に存在する凝固タンパク質のレベルが低いことが原因で起こります。出血性疾患検査は、疾患の症状がない方でも出血性疾患を発見するために実施されるスクリーニング検査です。有利な償還シナリオ、検査・診断における人工知能やナノ材料の統合の高まり、医療費の増大といった要因が、世界各地の市場需要の主な促進要因となっています。

一般人口における出血性疾患の有病率と診断の増加は、市場成長の触媒として作用しています。米国疾病対策予防センター（The Centers for Disease Control and Prevention）によると、血友病Aは男性の出生5,000人に1人が発症すると推定され、毎年約400人の赤ちゃんが血友病Aで生まれているとされています。同様に、世界血友病連盟の2020年年次世界調査によると、出血性疾患を患う人は世界で約393,658人記録されており、2015年の約287,066人から増加しています。この急増は、一般人口における診断のうち、本疾患の有病率が上昇したために発生し、その結果、世界中で市場の成長を加速させています。さらに、新製品の導入の増加や、主要な市場参加者による研究開発投資の増加が、予測期間中にさまざまな有利な機会をもたらしています。しかし、ガイドラインの遵守率の低さと血友病治療薬の高コストが、2022年から2029年の予測期間を通じて市場成長の妨げとなっています。

世界の出血性疾患検査市場の調査において考慮された主要地域は、アジア太平洋、北米、欧州、中南米、その他の世界です。欧州は、これらの疾患の診断に関するガイドラインの遵守率の上昇と規制当局の承認数の増加により、収益面で市場を独占しています。一方、アジア太平洋地域は、新興国における医療インフラの整備、出血性疾患の有病率の上昇、市場空間における患者数の増加などの要因から、予測期間中に最も高いCAGRで成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントおよび国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における業界の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

• 市場スナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • 出血性疾患検査市場：地域別、2019-2029年
  • 出血性疾患検査市場：製品タイプ別、2019-2029年
  • 出血性疾患検査市場：適応症別、2019-2029年
  • 出血性疾患検査市場：エンドユーザー別、2019-2029年
• 主な動向
• 調査手法の紹介
• 調査前提条件

第2章 出血性疾患検査の世界市場定義と範囲

• 調査の目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 調査対象年
• 通貨換算レート

第3章 出血性疾患検査の世界市場力学

• 出血性疾患検査市場のインパクト分析（2019-2029年）
  • 市場促進要因
    • 検査・診断における人工知能とナノマテリアルの統合の高まり
    • 出血性疾患の有病率と診断の増加
  • 市場の課題
    • ガイドラインの遵守率の低さ
    • 血友病治療薬の高コスト
  • 市場機会
    • 新製品のイントロダクションの増加
    • 主要な市場参入企業別研究開発投資の増加

第4章 世界の出血性疾患検査市場の産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • 社会的
  • 技術的
• トップ投資機会
• 主要成功戦略
• 業界専門家別展望
• アナリストの結論・提言

第5章 リスク評価：COVID-19のインパクト

• COVID-19が業界に与える全体的な影響の評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 出血性疾患検査の世界市場：製品タイプ別

• 市場スナップショット
• 出血性疾患検査の世界市場：製品タイプ別、実績-ポテンシャル分析
• 出血性疾患検査の世界市場、製品タイプ別推定・予測2019～2029年
• 出血性疾患検査の市場、サブセグメント分析
  • 試薬・消耗品
  • 器具類

第7章：出血性疾患検査の世界市場：適応症別

• 市場スナップショット
• 出血性疾患検査の世界市場：適応症別、実績-ポテンシャル分析
• 出血性疾患検査の世界市場、適応症別推定・予測2019-2029年
• 出血性疾患検査市場、サブセグメント分析
  • 血友病A
  • 血友病B
  • フォンウィルブランド病
  • 特発性血小板減少性紫斑病（Idiopathic Thrombocytopenic Purpura
  • その他

第8章 出血性疾患検査の世界市場：エンドユーザー別

• 市場スナップショット
• 出血性疾患検査の世界市場：エンドユーザー別実績-ポテンシャル分析
• 出血性疾患検査の世界市場、エンドユーザー別推定・予測2019～2029年
• 出血性疾患検査の市場、サブセグメント分析
  • 病院・診療所
  • 診断センター
  • その他

第9章 出血性疾患検査の世界市場：地域別分析

• 出血性疾患検査市場、地域別市場スナップショット
• 北米
  • 米国
    • 製品タイプ別の推定・予測、2019-2029年
    • 適応症別の推定・予測、2019年～2029年
    • エンドユーザー別の推定・予測、2019年～2029年
  • カナダ
• 欧州出血性疾患検査市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州地域
• アジア太平洋地域の出血性疾患検査市場のスナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの出血性疾患検査市場のスナップショット
  • ブラジル
  • メキシコ
  • その他のラテンアメリカ地域
• 世界のその他の地域

第10章 競合情報

• トップ市場戦略
• 企業プロファイル
  • F. Hoffmann-La Roche Ltd.
    • 主要情報
    • 概要
    • 財務情報（データの入手状況により異なります）
    • 製品概要
    • 最近の動向
  • Siemens Healthcare GmbH
  • HORIBA Ltd.
  • Sysmex Corporation
  • Abbott
  • Thermo Fisher Scientific Inc.
  • Biomerica, Inc.
  • Becton, Dickinson, and Company
  • Quest Diagnostics
  • Trinity Biotech Plc

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査属性
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Bleeding Disorder Testing Market, report scope
• TABLE 2. Global Bleeding Disorder Testing Market estimates & forecasts by Region 2019-2029 (USD Million)
• TABLE 3. Global Bleeding Disorder Testing Market estimates & forecasts by Product Type 2019-2029 (USD Million)
• TABLE 4. Global Bleeding Disorder Testing Market estimates & forecasts by Indication 2019-2029 (USD Million)
• TABLE 5. Global Bleeding Disorder Testing Market estimates & forecasts by End-user 2019-2029 (USD Million)
• TABLE 6. Global Bleeding Disorder Testing Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 7. Global Bleeding Disorder Testing Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 8. Global Bleeding Disorder Testing Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 9. Global Bleeding Disorder Testing Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 10. Global Bleeding Disorder Testing Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 11. Global Bleeding Disorder Testing Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 12. Global Bleeding Disorder Testing Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 13. Global Bleeding Disorder Testing Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 14. Global Bleeding Disorder Testing Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 15. Global Bleeding Disorder Testing Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 16. U.S. Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 17. U.S. Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 18. U.S. Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 19. Canada Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 20. Canada Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 21. Canada Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 22. UK Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 23. UK Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 24. UK Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 25. Germany Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 26. Germany Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 27. Germany Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 28. France Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 29. France Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 30. France Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 31. Italy Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 32. Italy Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 33. Italy Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 34. Spain Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 35. Spain Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 36. Spain Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 37. RoE Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 38. RoE Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 39. RoE Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 40. China Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 41. China Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 42. China Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 43. India Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 44. India Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 45. India Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 46. Japan Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 47. Japan Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 48. Japan Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 49. South Korea Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 50. South Korea Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 51. South Korea Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 52. Australia Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 53. Australia Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 54. Australia Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 55. RoAPAC Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 56. RoAPAC Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 57. RoAPAC Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 58. Brazil Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 59. Brazil Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 60. Brazil Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 61. Mexico Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 62. Mexico Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 63. Mexico Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 64. RoLA Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 65. RoLA Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 66. RoLA Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 67. Row Bleeding Disorder Testing Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 68. Row Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 69. Row Bleeding Disorder Testing Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 70. List of secondary sources, used in the study of global Bleeding Disorder Testing Market
• TABLE 71. List of primary sources, used in the study of global Bleeding Disorder Testing Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Bleeding Disorder Testing Market, research methodology
• FIG 2. Global Bleeding Disorder Testing Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Bleeding Disorder Testing Market, key trends 2021
• FIG 5. Global Bleeding Disorder Testing Market, growth prospects 2022-2029
• FIG 6. Global Bleeding Disorder Testing Market, porters 5 force model
• FIG 7. Global Bleeding Disorder Testing Market, pest analysis
• FIG 8. Global Bleeding Disorder Testing Market, value chain analysis
• FIG 9. Global Bleeding Disorder Testing Market by segment, 2019 & 2029 (USD Million)
• FIG 10. Global Bleeding Disorder Testing Market by segment, 2019 & 2029 (USD Million)
• FIG 11. Global Bleeding Disorder Testing Market by segment, 2019 & 2029 (USD Million)
• FIG 12. Global Bleeding Disorder Testing Market by segment, 2019 & 2029 (USD Million)
• FIG 13. Global Bleeding Disorder Testing Market by segment, 2019 & 2029 (USD Million)
• FIG 14. Global Bleeding Disorder Testing Market, regional snapshot 2019 & 2029
• FIG 15. North America Bleeding Disorder Testing Market 2019 & 2029 (USD Million)
• FIG 16. Europe Bleeding Disorder Testing Market 2019 & 2029 (USD Million)
• FIG 17. Asia pacific Bleeding Disorder Testing Market 2019 & 2029 (USD Million)
• FIG 18. Latin America Bleeding Disorder Testing Market 2019 & 2029 (USD Million)
• FIG 19. Global Bleeding Disorder Testing Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Bleeding Disorder Testing Market is valued at approximately USD 82.6 million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2022-2029. Bleeding disorder is a condition that affects when the blood clotting process and resulting in excessive bleeding. This disorder is caused by the low levels of clotting protein that is present in blood. Bleeding disorder testing is a screening test that is performed to detect bleeding disorders in people who have not shown any symptoms of disease. Factors such as favorable reimbursement scenarios, rising integration of artificial intelligence and nanomaterials in testing and diagnosis, coupled with the growing healthcare expenditure are the chief driving factors for the market demand around the world.

The increasing prevalence and diagnosis of bleeding disorder among general population is acting as a catalyzing factor for the growth of the market. According to The Centers for Disease Control and Prevention, it was estimated that Hemophilia A affects 1 in 5,000 male births and nearly 400 babies are born with hemophilia A each year. Likewise, as per the World Federation of Hemophilia's 2020 annual global survey, there were around 393,658 individuals worldwide recorded who suffer from bleeding disorders, which is an increase from about 287,066 in 2015. This surge occurs because of a rise in the disorder's prevalence among diagnoses in the general population, thus, in turn, accelerates the market growth across the globe. Moreover, the rising introduction of new products, as well as the growing R&D investment by the key market players are presenting various lucrative opportunities over the forecasting years. However, the low adherence to guidelines and high cost of hemophilia drugs are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Bleeding Disorder Testing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Europe dominated the market in terms of revenue, owing to the rising adherence to the guidelines for diagnosis of these disorders and the rising number of regulatory approvals. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as development of healthcare infrastructure in emerging countries, rising prevalence of bleeding disorder, and rising number of patient population in the market space.

Major market players included in this report are:

F. Hoffmann-La Roche Ltd.

Siemens Healthcare GmbH

HORIBA Ltd.

Sysmex Corporation

Abbott

Thermo Fisher Scientific Inc.

Biomerica, Inc.

Becton, Dickinson, and Company

Quest Diagnostics

Trinity Biotech Plc

Recent Developments in the Market:

• In July 2022, HORIBA, Ltd. announced the launch of the company's new product Yumizen H500 and H550 hematology which offers better performance, new features, and increased benefits.
• In February 2022, Sysmex Corporation unveiled the establishment of Sysmex LLC- the company's new subsidiary in Saudi Arabia. The aim of this initiative is to boost the sales and services structure in Saudi Arabia. The new subsidiary is emphasizing on strengthening its hemostasis, hematology, and urinalysis markets.

Global Bleeding Disorder Testing Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product Type, Indication, End-user, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Reagents & Consumables

Instruments

By Indication:

Hemophilia A

Hemophilia B

Von Willebrand Disease

Idiopathic Thrombocytopenic Purpura

Others

By End-user:

Hospitals & Clinics

Diagnostic Centers

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
  • 1.2.1. Bleeding Disorder Testing Market, by Region, 2019-2029 (USD Million)
  • 1.2.2. Bleeding Disorder Testing Market, by Product Type, 2019-2029 (USD Million)
  • 1.2.3. Bleeding Disorder Testing Market, by Indication, 2019-2029 (USD Million)
  • 1.2.4. Bleeding Disorder Testing Market, by End-user, 2019-2029 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Bleeding Disorder Testing Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Bleeding Disorder Testing Market Dynamics

• 3.1. Bleeding Disorder Testing Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising integration of artificial intelligence and nanomaterials in testing and diagnosis
    • 3.1.1.2. Increasing prevalence and diagnosis of bleeding disorder
  • 3.1.2. Market Challenges
    • 3.1.2.1. Low adherence to guidelines
    • 3.1.2.2. High cost of haemophilia drugs
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising introduction of new products
    • 3.1.3.2. Growing R&D investment by the key market players

Chapter 4. Global Bleeding Disorder Testing Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Bleeding Disorder Testing Market, by Product Type

• 6.1. Market Snapshot
• 6.2. Global Bleeding Disorder Testing Market by Product Type, Performance - Potential Analysis
• 6.3. Global Bleeding Disorder Testing Market Estimates & Forecasts by Product Type 2019-2029 (USD Million)
• 6.4. Bleeding Disorder Testing Market, Sub Segment Analysis
  • 6.4.1. Reagents & Consumables
  • 6.4.2. Instruments

Chapter 7. Global Bleeding Disorder Testing Market, by Indication

• 7.1. Market Snapshot
• 7.2. Global Bleeding Disorder Testing Market by Indication, Performance - Potential Analysis
• 7.3. Global Bleeding Disorder Testing Market Estimates & Forecasts by Indication 2019-2029 (USD Million)
• 7.4. Bleeding Disorder Testing Market, Sub Segment Analysis
  • 7.4.1. Hemophilia A
  • 7.4.2. Hemophilia B
  • 7.4.3. Von Willebrand Disease
  • 7.4.4. Idiopathic Thrombocytopenic Purpura
  • 7.4.5. Others

Chapter 8. Global Bleeding Disorder Testing Market, by End-user

• 8.1. Market Snapshot
• 8.2. Global Bleeding Disorder Testing Market by End-user, Performance - Potential Analysis
• 8.3. Global Bleeding Disorder Testing Market Estimates & Forecasts by End-user 2019-2029 (USD Million)
• 8.4. Bleeding Disorder Testing Market, Sub Segment Analysis
  • 8.4.1. Hospitals & Clinics
  • 8.4.2. Diagnostic Centers
  • 8.4.3. Others

Chapter 9. Global Bleeding Disorder Testing Market, Regional Analysis

• 9.1. Bleeding Disorder Testing Market, Regional Market Snapshot
• 9.2. North America Bleeding Disorder Testing Market
  • 9.2.1. U.S. Bleeding Disorder Testing Market
    • 9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Bleeding Disorder Testing Market
• 9.3. Europe Bleeding Disorder Testing Market Snapshot
  • 9.3.1. U.K. Bleeding Disorder Testing Market
  • 9.3.2. Germany Bleeding Disorder Testing Market
  • 9.3.3. France Bleeding Disorder Testing Market
  • 9.3.4. Spain Bleeding Disorder Testing Market
  • 9.3.5. Italy Bleeding Disorder Testing Market
  • 9.3.6. Rest of Europe Bleeding Disorder Testing Market
• 9.4. Asia-Pacific Bleeding Disorder Testing Market Snapshot
  • 9.4.1. China Bleeding Disorder Testing Market
  • 9.4.2. India Bleeding Disorder Testing Market
  • 9.4.3. Japan Bleeding Disorder Testing Market
  • 9.4.4. Australia Bleeding Disorder Testing Market
  • 9.4.5. South Korea Bleeding Disorder Testing Market
  • 9.4.6. Rest of Asia Pacific Bleeding Disorder Testing Market
• 9.5. Latin America Bleeding Disorder Testing Market Snapshot
  • 9.5.1. Brazil Bleeding Disorder Testing Market
  • 9.5.2. Mexico Bleeding Disorder Testing Market
  • 9.5.3. Rest of Latin America Bleeding Disorder Testing Market
• 9.6. Rest of The World Bleeding Disorder Testing Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. F. Hoffmann-La Roche Ltd.
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Siemens Healthcare GmbH
  • 10.2.3. HORIBA Ltd.
  • 10.2.4. Sysmex Corporation
  • 10.2.5. Abbott
  • 10.2.6. Thermo Fisher Scientific Inc.
  • 10.2.7. Biomerica, Inc.
  • 10.2.8. Becton, Dickinson, and Company
  • 10.2.9. Quest Diagnostics
  • 10.2.10. Trinity Biotech Plc

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption